IL43080A - 3,4-dihydropyridones,their production and pharmaceutical compositions containing them - Google Patents

3,4-dihydropyridones,their production and pharmaceutical compositions containing them

Info

Publication number
IL43080A
IL43080A IL43080A IL4308073A IL43080A IL 43080 A IL43080 A IL 43080A IL 43080 A IL43080 A IL 43080A IL 4308073 A IL4308073 A IL 4308073A IL 43080 A IL43080 A IL 43080A
Authority
IL
Israel
Prior art keywords
compound
ester
alkyl
diethyl ester
amino
Prior art date
Application number
IL43080A
Other languages
English (en)
Other versions
IL43080A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL43080A0 publication Critical patent/IL43080A0/xx
Publication of IL43080A publication Critical patent/IL43080A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
IL43080A 1972-08-31 1973-08-27 3,4-dihydropyridones,their production and pharmaceutical compositions containing them IL43080A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2242787A DE2242787C2 (de) 1972-08-31 1972-08-31 4-Phenyl-6-amino-3,4-dihydropyridon-(2)-3,5-dicarbonsäure-diäthylesterderivate, ein Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
IL43080A0 IL43080A0 (en) 1973-11-28
IL43080A true IL43080A (en) 1977-01-31

Family

ID=5855065

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43080A IL43080A (en) 1972-08-31 1973-08-27 3,4-dihydropyridones,their production and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US3925395A (da)
JP (1) JPS5626661B2 (da)
AT (1) AT327902B (da)
AU (1) AU476373B2 (da)
BE (1) BE804161A (da)
CA (1) CA1016946A (da)
CH (1) CH592061A5 (da)
DD (1) DD109628A5 (da)
DE (1) DE2242787C2 (da)
DK (1) DK131855C (da)
ES (1) ES418340A1 (da)
FR (1) FR2197598B1 (da)
GB (1) GB1389505A (da)
HU (1) HU167992B (da)
IE (1) IE38141B1 (da)
IL (1) IL43080A (da)
LU (1) LU68325A1 (da)
NL (1) NL7311832A (da)
PL (1) PL89430B1 (da)
SE (1) SE385882B (da)
ZA (1) ZA735973B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002762A (en) * 1973-03-03 1977-01-11 Bayer Aktiengesellschaft 2-Amino-3,4-dihydropyridines used to effect coronary vessel dilation and treat hypertension
IT8367883A0 (it) * 1982-08-23 1983-08-22 Rorer Int Overseas Composti cardiotonici del 2 piridone 5 biciclico eteroaril sostituito e relative composizioni farmaceutiche
WO1993009774A1 (en) * 1991-11-18 1993-05-27 G.D. Searle & Co. 2-(4-substituted)phenylmethylene derivatives and methods of use
AU2003293356A1 (en) 2002-08-27 2004-03-19 Bayer Healthcare Ag Dihydropyridinone derivatives as hne inhibitors
US20050252833A1 (en) * 2004-05-14 2005-11-17 Doyle James A Process and apparatus for converting oil shale or oil sand (tar sand) to oil

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
ZA7152B (en) * 1970-01-24 1971-10-27 Bayer Ag New pharmaceutically active 1,4-dihydropyridines

Also Published As

Publication number Publication date
AU5983573A (en) 1975-03-06
ATA760073A (de) 1975-05-15
DK131855C (da) 1976-02-16
ES418340A1 (es) 1976-03-16
GB1389505A (en) 1975-04-03
FR2197598A1 (da) 1974-03-29
DD109628A5 (da) 1974-11-12
ZA735973B (en) 1974-10-30
FR2197598B1 (da) 1977-07-15
DE2242787A1 (de) 1974-03-14
HU167992B (da) 1976-02-28
AT327902B (de) 1976-02-25
JPS5626661B2 (da) 1981-06-19
CA1016946A (en) 1977-09-06
JPS4962483A (da) 1974-06-17
DE2242787C2 (de) 1982-01-21
LU68325A1 (da) 1973-10-30
BE804161A (fr) 1974-02-28
US3925395A (en) 1975-12-09
SE385882B (sv) 1976-07-26
PL89430B1 (da) 1976-11-30
AU476373B2 (en) 1976-09-16
IL43080A0 (en) 1973-11-28
CH592061A5 (da) 1977-10-14
NL7311832A (da) 1974-03-04
DK131855B (da) 1975-09-15
IE38141B1 (en) 1978-01-04
IE38141L (en) 1974-02-28

Similar Documents

Publication Publication Date Title
US4248873A (en) Nitro-substituted 1,4-dihydropyridines, processes for _their production and their medicinal use
US4551467A (en) Vasodilating cyanoalkyl esters of 1,4-dihydropyridines
IL42458A (en) 1,4-dihydropyridines their production and pharmaceutical compositions containing them
IE50504B1 (en) Optically active 1,4-dihydropyridine compounds,their production and their medicinal use
IL41668A (en) N-Transformed History of Dihydropyridine, Their Manufacture, and Pharmaceutical Preparations Containing Them
US4177278A (en) 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
JPS6025424B2 (ja) １，４‐ジヒドロピリジンカルボン酸アラルキルエステル
GB1560280A (en) 1,4-dihydrohpyrid-ine derivatives substituted in the 2 position processes for their preparation and their use as medicaments
US3905983A (en) 3,5,6-Tricarboxy- and 2,3,5,6-tetracarboxy-1,4-dihydropyridine derivatives
US4256749A (en) Fluorine-containing 1,4-dihydropyridine compounds, pharmaceutical compositions thereof and their medicinal use
IL36320A (en) 4-azidophenyl-1,4-dihydropyridine dicarboxylic acid ester derivatives,their preparation and pharmaceutical compositions containing them
CA1108615A (en) Dihydropyridine compounds, their production and their medicinal use
CA1179342A (en) 1,4-dihydropyridine compounds linked in the c-3 position, their production and their medicinal use
US4237137A (en) Sila-substituted 1,4-dihydropyridine derivatives and their medicinal use
US3946027A (en) 3,5,6-Tricarboxy-4-pyridyl-1,4-dihydropyridine derivatives
CA1175438A (en) 1,4-dihydropyridine compounds having different substituents in the 2-position and 6-position, their production, and their medicinal use
US4146627A (en) Aminoalkylideamino-1,4-dihydropyridines and their use as medicaments
CH647519A5 (de) Bluthochdruck senkende amine.
IL43080A (en) 3,4-dihydropyridones,their production and pharmaceutical compositions containing them
US3946028A (en) 2,3,5,6-Tetracarboxy-4-pyridyl-1,4-dihydropyridine derivatives
IL42933A (en) 2- Alcalamino dihydropyridines, their manufacture and pharmaceutical preparations containing them
US4162321A (en) Sulphur-containing amino-dihydropyridines, and their use as medicants
US3943140A (en) 2,3,5,6-Tetracarboxy-1,4-dihydropyridine derivatives
US4166855A (en) 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid ester, and its use as a peripheral vasodilator
US4364952A (en) Certain 1,4-dihydro-2,6-dimethyl-3,5-pyridine-dicarboxylates, composition containing same and method of use